Citation: Pc. Gray et al., Antagonism of activin by inhibin and inhibin receptors: a functional role for betaglycan-glycan, MOL C ENDOC, 180(1-2), 2001, pp. 47-53
Authors:
Lee, S
Smith, GW
Vale, W
Lee, KF
Rivier, C
Citation: S. Lee et al., Mice that lack corticotropin-releasing factor (CRF) receptors type 1 show a blunted ACTH response to acute alcohol despite up-regulated constitutive hypothalamic CRF gene expression, ALC CLIN EX, 25(3), 2001, pp. 427-433
Authors:
Currie, PJ
Coscina, DV
Bishop, C
Coiro, CD
Koob, GF
Rivier, J
Vale, W
Citation: Pj. Currie et al., Hypothalamic paraventricular nucleus injections of urocortin alter food intake and respiratory quotient, BRAIN RES, 916(1-2), 2001, pp. 222-228
Authors:
Spina, MG
Basso, AM
Zorrilla, EP
Heyser, CJ
Rivier, J
Vale, W
Merlo-Pich, E
Koob, GF
Citation: Mg. Spina et al., Behavioral effects of central administration of the novel CRF antagonist astressin in rats, NEUROPSYCH, 22(3), 2000, pp. 230-239
Authors:
Van Pett, K
Viau, V
Bittencourt, JC
Chan, RKW
Li, HY
Arias, C
Prins, GS
Perrin, M
Vale, W
Sawchenko, PE
Citation: K. Van Pett et al., Distribution of mRNAs encoding CRF receptors in brain and pituitary of batand mouse, J COMP NEUR, 428(2), 2000, pp. 191-212
Authors:
Gray, PC
Greenwald, J
Blount, AL
Kunitake, KS
Donaldson, CJ
Choe, S
Vale, W
Citation: Pc. Gray et al., Identification of a binding site on the type II activin receptor for activin and inhibin, J BIOL CHEM, 275(5), 2000, pp. 3206-3212
Citation: Lx. Wang et al., Fos induction in selective hypothalamic neuroendocrine and medullary nuclei by intravenous injection of urocortin and corticotropin-releasing factor in rats, BRAIN RES, 855(1), 2000, pp. 47-57
Authors:
Basso, AM
Spina, M
Rivier, J
Vale, W
Koob, GF
Citation: Am. Basso et al., Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like"effect in the defensive burying paradigm but not in the elevated plus-mazefollowing chronic cocaine in rats, PSYCHOPHAR, 145(1), 1999, pp. 21-30
Authors:
Fischer, WH
Greenwald, J
Park, M
Craig, AG
Choe, S
Vale, W
Citation: Wh. Fischer et al., The disulfide bond arrangement in the extracellular domain of the activin type II receptor, J PROTEIN C, 18(4), 1999, pp. 437-446
Authors:
Cervini, L
Theobald, P
Corrigan, A
Craig, AG
Rivier, C
Vale, W
Rivier, J
Citation: L. Cervini et al., Corticotropin releasing factor (CRF) agonists with reduced amide bonds andSer(7) substitutions, J MED CHEM, 42(4), 1999, pp. 761-768
Authors:
Petraglia, F
Florio, P
Benedetto, C
Marozio, L
Di Blasio, AM
Ticconi, C
Piccione, E
Luisi, S
Genazzani, AR
Vale, W
Citation: F. Petraglia et al., Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro, J CLIN END, 84(4), 1999, pp. 1420-1423
Authors:
Contarino, A
Dellu, F
Koob, GF
Smith, GW
Lee, KF
Vale, W
Gold, LH
Citation: A. Contarino et al., Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1, BRAIN RES, 835(1), 1999, pp. 1-9
Authors:
Koerber, SC
Gulyas, J
Lahrichi, SL
Corrigan, A
Craig, AG
Rivier, C
Vale, W
Rivier, J
Citation: Sc. Koerber et al., Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges, J MED CHEM, 41(25), 1998, pp. 5002-5011
Authors:
Rivier, J
Gulyas, J
Corrigan, A
Martinez, V
Craig, AG
Tache, Y
Vale, W
Rivier, C
Citation: J. Rivier et al., Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the rat, J MED CHEM, 41(25), 1998, pp. 5012-5019
Authors:
Greenwald, J
Le, V
Corrigan, A
Fischer, W
Komives, E
Vale, W
Choe, S
Citation: J. Greenwald et al., Characterization of the extracellular ligand-binding domain of the type IIactivin receptor, BIOCHEM, 37(47), 1998, pp. 16711-16718